What is Sarepta Therapeutics, Inc.'s EPS (diluted)?

Sarepta Therapeutics, Inc. (SRPT) reported EPS (diluted) of -$4.60 in Q1 2025.

How has Sarepta Therapeutics, Inc.'s EPS (diluted) changed year-over-year?

Sarepta Therapeutics, Inc.'s EPS (diluted) decreased by 1343.2% year-over-year, from $0.37 to -$4.60.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Sarepta Therapeutics, Inc. SRPT EPS (Diluted)

Discontinued — last reported Q1 '25

EPS (Diluted) at other companies

PfizerPFE

$0.47-9.6%

Regeneron PharmaceuticalsREGN

$6.75-7.2%

BioMarin PharmaceuticalsBMRN

$0.54-43.2%

PTC TherapeuticsPTCT

-$0.03-100%

InsmedINSM

-$0.76+46.5%

Capricor TherapeuticsCAPR

-$0.59-11.3%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s EPS (diluted)?: Sarepta Therapeutics, Inc. (SRPT) reported EPS (diluted) of -$4.60 in Q1 2025.
How has Sarepta Therapeutics, Inc.'s EPS (diluted) changed year-over-year?: Sarepta Therapeutics, Inc.'s EPS (diluted) decreased by 1343.2% year-over-year, from $0.37 to -$4.60.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.